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ABSTRACT
The Immune Epitope Database Analysis Resource
(IEDB-AR, http://tools.iedb.org/) is a companion web-
site to the IEDB that provides computational tools
focused on the prediction and analysis of B and
T cell epitopes. All of the tools are freely available
through the public website and many are also avail-
able through a REST API and/or a downloadable
command-line tool. A virtual machine image of the
entire site is also freely available for non-commercial
use and contains most of the tools on the public site.
Here, we describe the tools and functionalities that
are available in the IEDB-AR, focusing on the 10 new
tools that have been added since the last report in
the 2012 NAR webserver edition. In addition, many of
the tools that were already hosted on the site in 2012
have received updates to newest versions, includ-
ing NetMHC, NetMHCpan, BepiPred and DiscoTope.
Overall, this IEDB-AR update provides a substantial
set of updated and novel features for epitope predic-
tion and analysis.
INTRODUCTION
The adaptive immune system in vertebrates can recognize
a large repertoire of antigens from a broad spectrum of
pathogens. B and T cell receptors are responsible for recog-
nizing these diverse set of antigens and triggering immune
responses. The specific regions recognized on these antigens
by B and T cell receptors are termed as epitopes. Thus, un-
derstanding the mechanism of immune receptor:epitope in-
teractions is important in developing diagnostics, therapeu-
tics, and vaccines against infectious and autoimmune dis-
eases, cancers and allergies.
The Immune Epitope Database (IEDB) captures exper-
iments that identify and characterize epitopes and epitope
specific immune receptors along with various other details
such as host organism, immune exposures, and induced im-
mune responses (1). A companion site, IEDB-Analysis Re-
source (IEDB-AR), hosts various B and T cell epitope pre-
diction tools based on algorithms trained and validated on
the IEDB data along with epitope analysis tools. Since the
last update, the number of monthly users visiting the IEDB-
AR has more than tripled from under 1,500 in 2012 to
over 4,500 in 2018 (Supplementary Figure S1). New epi-
tope prediction and analysis tools are regularly added in
the IEDB-AR with features to advance epitope-based ther-
apeutics and vaccine development (2). For example, a tool
to reduce undesired immunogenicity of therapeutic proteins
was implemented recently (3). Here, we describe the newly
implemented tools (Table 1), updates to the previously ex-
isting tools, and novel functionalities that have been added
since the last report in the 2012 NAR webserver edition (4).
T CELL EPITOPE PREDICTION TOOLS
A total of 6 new tools were added in the category of T cell
epitope prediction. These include TepiTool, a T cell pep-
tide:MHC binding prediction tool with a new user-friendly
interface, tools for prediction of naturally processed MHC
class I and class II ligands, deimmunization of therapeutic
proteins and prediction of T cell immunogenicity beyond
MHC binding affinity. In addition to the newly added tools,
many of the previously existing tools have been re-trained
and updated as more data were made available. The latest
versions of the prediction methods in T cell epitope predic-
tion tools are listed in Table 2. While the latest versions are
provided as the default methods, many of the tools allow the
user to select previous versions where available. The newly
added tools are described briefly in the following sections.
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Table 1. New and updated tools in the IEDB-AR
Category Name Update type Key features Purpose
T cell TepiTool New tool Interactive and easy to use tool for
immunologists
Prediction of T cell epitopes.
MHC-NP New tool Uses binding and ligand elution data to
train the model.
Prediction of naturally processed ligands
for MHC class I.
MHCII-NP New tool Uses motif informations in the ligand
elution dataset from IEDB
Prediction of naturally processed ligands
for MHC class II.
Immunogenicity New tool Uses properties and position of amino
acids to predict immunogenicity
Predicting immunogenicity for
MHC-class I epitopes.
CD4EpiScore New tool Combines the prediction from
immunogenicity and MHC binding
algorithms
Predicting CD4 T cell reactivity in
human population.
Deimmunization New tool Predicts non-immunogenic regions based
on reduced binding to a set of reference
MHC II alleles
Identification of immunogenic regions
and suggested amino acid substitutions
to reduce immunogenicity.
B cell / T cell LYRA New tool Easy to use and fast antibody and TCR
structure prediction.
Template-based 3D structure modeling
of B- and T-cell receptors.
B cell BepiPred2.0 New version Training on conformational epitope
dataset using random forest algorithm
Prediction of linear B-cell epitopes.
DiscoTope2.0 New version Novel spatial neighborhood and surface
exposure definitions.
Prediction of discontinuous B-cell
epitopes.
Analysis tools RATE New tool Infers HLA restriction by generating a
matrix of subjects and given immune
response
Inferring allele restriction for epitopes
based on immune response data from
HLA-typed subjects.
ImmunomeBrowser New tool User specified epitopes and source
proteins.
Aggregating and mapping the immune
response from heterogeneous epitope
data to source proteins.
Cluster2.0 Re-engineered Multiple clustering methods and
visualization.
Grouping and visualizing peptides
similar in sequence.
Table 2. Methods and versions available in the IEDB T cell epitope prediction tools
MHC class Prediction method Versions available Reference
MHC class I IEDB consensus (Recommendeda) 2.18 (default) Moutaftsi et al. (22)
NetMHCpan 4.0 (default), 3.0, 2.8 Jurtz et al. (23)
NetMHC (also called ANN) 4.0 (default), 3.4 Andreatta and Nielsen (24)
SMMPMBEC 1.0 Kim et al. (25)
SMM 1.0 Peters and Sette (26)
Comblib sidney2008 1.0 Sidney et al. (27)
PickPocket 1.1 Zhang et al. (28)
NetMHCcons 1.1 Karosiene et al. (29)
netMHCstabpan 1.0 Rasmussen et al. (30)
MHC II IEDB consensus (Recommendeda) 2.17 Wang et al. (31)
NetMHCIIpan 3.1 Andreatta et al. (32)
NN-align 2.2 Nielsen and Lund (33)
SMM-align 1.1 Nielsen et al. (34)
Combinatorial Library 1.0 Sidney et al. (27)
Sturniolo 1.0 Sturniolo et al. (35)
aRecommended methods can change based on regular benchmarking evaluations.
TepiTool
TepiTool (http://tools.iedb.org/tepitool) (5) is a new inter-
face for IEDB T cell epitope predictions and is designed as a
step-by-step wizard combining both MHC class I and class
II prediction methods. The tool provides recommended de-
fault values at each step for the prediction and selection
of an optimal set of peptides for a given application. Tepi-
Tool also offers additional functionalities that go beyond
binding predictions. For example, conservancy analysis of
peptides among the input sequences and different options
for selecting the top-predicted peptides. Once the predic-
tion task is finished, the user is provided with a concise set
of top-predicted peptides and links to download the com-
plete prediction results and conservancy estimates. The pre-
diction results and links are also emailed to the user, if an
email address is provided.
Prediction of naturally processed ligands for MHC class I
and class II
MHC-NP (http://tools.iedb.org/mhcnp) (6) is a tool for pre-
dicting peptides that are naturally processed by the MHC
class I pathway and bind to MHC class I molecules. The
tool can predict MHC I ligands for six human and two
mouse MHC alleles. Similarly, MHCII-NP (http://tools.
iedb.org/mhciinp) (7) is a tool for predicting naturally pro-
cessed MHC II ligands. These tools were developed by
training on the naturally processed peptides eluted from
MHC molecules.
Immunogenicity
This new tool (http://tools.iedb.org/immunogenicity) is in-
tended to classify peptides that bind to MHC class I
(pMHC) into two categories: epitopes and non-epitopes (8).
It is based on an analysis of amino acid composition of the
peptide at non-anchor positions, where the side chains of
amino acids are likely to be in contact with the TCR.
CD4EpiScore
CD4EpiScore (http://tools.iedb.org/cd4episcore) is a new
tool for predicting the immunogenicity of CD4-restricted
peptides in human populations that utilizes a neural net-
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(9). It has been validated on a series of independent datasets
reported in the literature for different ethnicities and diverse
antigens using a variety of experimental approaches.
Deimmunization
The Deimmunization tool (http://tools.iedb.org/
deimmunization) was added to IEDB-AR to address
the issue of undesired immune reactivity to therapeutically
important proteins. In a stepwise wizard, this tool makes
use of the class II peptide:MHC binding prediction tools
to predict potentially immunogenic regions in protein
sequences and suggest amino acid substitutions to reduce
their immunogenicity (3). As a proof-of-concept, the tool
has been validated experimentally on recombinant factor
VIIa (Vatreptacog alpha), which was discontinued from
clinical trials due to immunogenicity issues (10).
B CELL EPITOPE PREDICTION TOOLS
The IEDB-AR hosts linear B cell epitope prediction tools,
such as BepiPred (11), various amino acid physicochemi-
cal property based scales (http://tools.iedb.org/bcell/), and
discontinuous B cell epitope prediction tools, such as Dis-
coTope (http://tools.iedb.org/discotope/) (12) and ElliPro
(http://tools.iedb.org/ellipro/) (13). Since the last update
of IEDB-AR, the recommended B cell epitope prediction
methods, BepiPred (14) and DiscoTope (15), were updated
to their 2.0 versions.
LYRA
A new tool named LYRA (Lymphocyte Receptor Auto-
mated Modelling) was added to model the 3D structures of
B and T cell receptors (16). The LYRA tool (http://tools.
iedb.org/lyra/) predicts the structure of B- and T-cell re-
ceptors from their amino acid sequence. Using homology
modelling, it selects the best framework templates and, if
necessary, models the complementary determining regions
(CDRs) based on the predicted canonical structure (17) of
each loop, which are then grafted onto the framework tem-
plates. The results page shows the aligned sequence and a
visualization of the structure allowing for quick inspection
of the CDRs in both sequence and structure.
ANALYSIS TOOLS
The analysis section of IEDB-AR contains tools that au-
tomate common tasks when working with sets of epitopes
or epitope-candidates. Updates to this section include a re-
vised version of epitope clustering along with a new tool
to map epitopes to source proteins, and a tool to infer al-
lele restrictions of epitopes from immune response data on
HLA-typed subjects.
Cluster2.0
The epitope clustering tool (http://tools.iedb.org/cluster2)
has been completely re-engineered to group peptidic epi-
topes based on their sequence similarity. In addition to pro-
viding three different clustering approaches, this new ver-
sion also supports interactive graphical visualizations of the
clusters to show connectivity among peptides (18).
ImmunomeBrowser
The ImmunomeBrowser tool in the IEDB website maps
epitopes to their source antigen and provides a visualiza-
tion of the observed immune responses across all tested re-
gions of the protein. In a new customizable version of this
tool (http://tools.iedb.org/immunomebrowser/), we have ex-
tended this application to perform a similar analysis for
user-provided datasets of epitopes and source antigens (19).
Restrictor Analysis Tool for Epitopes (RATE)
RATE (http://tools.iedb.org/rate) (20) is an automated
method that can computationally infer the HLA restric-
tions of epitopes, given large datasets of T cell responses in
HLA typed subjects. The tool takes two inputs, the alleles
expressed by the subjects and the immune response of the
peptides in the subjects. It then calculates the odds ratios for
each allele being the restricting allele for a specific peptide
and estimates significance using Fisher’s exact test. The tool
was developed with a focus on class II alleles but can also
be applied to class I alleles.
NEW FEATURES IN THE IEDB-AR
In addition to implementing new tools, IEDB-AR develop-
ment since 2012 has also targeted improvements that ad-
dress how users want to interact with the tools. Two of the
most readily apparent and prevalent new features are the
ability to submit prediction jobs for processing in the back-
ground and the architectural changes made at the hardware
and software levels to improve stability and support paral-
lelization.
Background batch job processing
With the release of version 2.17 of the IEDB-AR in June
2017, users were given the ability to provide an email ad-
dress upon submission of a class I or class II peptide bind-
ing prediction job. This enhancement has allowed users to
run larger prediction jobs (in terms of the number of in-
put sequences and predicted alleles) than would be possi-
ble directly through the web interface. Upon completion
of the job, results are sent as an email attachment to the
user. Since the initial implementation, this feature has been
added to TepiTool and the Deimmunization tool - both of
which are computationally intensive and could timeout with
a reasonable-sized request through the web interface. For
tools that support batch processing, it is available through
the web interface as well as the API.
Hardware & software architectural changes to improve sta-
bility and support parallelization
Several architectural changes have been made to the hard-
ware and software in order to decouple the front-end from
the back-end, improve stability, and support paralleliza-
tion of several tools. At the hardware level, a separate job-
processing cluster was created to run all CPU-intensive
tasks, such as binding predictions. These machines are phys-
ically separated from the web server so that heavy process-
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of the redesigned server architecture, the backend software
was completely reengineered in Python and Django with
special attention to make use of a message queuing sys-
tem (RabbitMQ) and task manager (Celery). With this in-
tegrated system in place, it has allowed parallelization of
jobs for several of the resource tools with speedups as great
as 15-fold over the single-threaded version. It has also en-
abled efficient use of resources and prioritization of jobs
based upon their origins. As an example, a separate resource
queue has been configured in collaboration with the Griffith
lab to support the CPU-intensive requests of their pVAC-
Seq pipeline (21) while keeping the IEDB systems respon-
sive to requests from other users.
AVAILABILITY OF THE TOOLS
IEDB application programming interface (IEDB-API)
In addition to the main web interface, public-facing APIs
are made available for several of the tools hosted at the
IEDB-AR. Included among these tools are the MHC class I
and class II binding and processing predictions, MHC-NP,
and the B cell linear epitope predictor. To provide a con-
sistent experience, each of the APIs adhere to a similar in-
terface, with parameter names shared among them where
possible. All of the APIs work via HTTP POST requests
and return responses in plain text. The MHC class I and II
binding prediction APIs are very heavily utilized, account-
ing for over 300,000 predictions each month and upward of
90% of the jobs run through the IEDB-AR.
Software distribution packages
While the goal of the public IEDB-AR server is to accom-
modate as many prediction jobs as reasonably possible, re-
sources can be limiting for extremely large requests. This is
one of the many reasons that the IEDB-AR team provides
downloadable packages to run the predictions locally on the
user hardware. Currently, 8 different standalone packages
are available, covering the most widely used tools, and new
packages are developed based upon user demand and avail-
able resources. Additionally, a complete virtual machine im-
age of the IEDB-AR is made available to external entities
through license agreements. These two modes of distribu-
tion cover a broad range of use cases, enabling users to run
many of the IEDB-AR tools on their own hardware and in
complete privacy.
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